Furie discussed topline data from the REGENCY trial and key secondary endpoints.
Richard Furie, MD
Advertisement
Articles by Richard Furie, MD
Furie discussed his experiences in evaluating therapies such as rituximab and now obinutuzumab for lupus nephritis.
Advertisement
Latest Updated Articles
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MDPublished: February 21st 2025 | Updated:
- Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Published: February 14th 2025 | Updated:
Advertisement
Advertisement